The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation
Abstract
Previous studies have shown that the oncogenic HPV E6 proteins form a complex with the human homologue of the Drosophila tumour suppressor protein, discs large (Dlg). This is mediated by the carboxy terminus of the E6 proteins and involves recognition of at least one PDZ domain of Dlg. This region of E6 is not conserved amongst E6 proteins from the low risk papillomavirus types and, hence, binding of HPV E6 proteins to Dlg correlates with the oncogenic potential of these viruses. We have performed studies to investigate the consequences of the interaction between E6 and Dlg. Mutational analysis of both the HPV18 E6 and Dlg proteins has further defined the regions of E6 and Dlg necessary for complex formation. Strikingly, co-expression of wild type HPV18 E6 with Dlg in vitro or in vivo results in a dramatic decrease in the amount of Dlg protein, whereas mutants of E6 which fail to complex with Dlg have minimal effect on Dlg protein levels. The oncogenic HPV16 E6 also decreased the Dlg levels, but this was not observed with the low risk HPV11 E6 protein. Moreover, a region within the first 544 amino acids of Dlg containing the three PDZ domains confers susceptibility to E6 mediated degradation. Finally, treatment of cells with a proteasome inhibitor overrides the capacity of E6 to degrade Dlg. These results demonstrate that Dlg is targeted by high risk HPV E6 proteins for proteasome mediated degradation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“hDlg, hScrib and MAGI-1 are tumour suppressors; the loss of these proteins facilitates cancer formation (reviewed in [275,276]), and all high-risk E6 proteins target them for proteasome-mediated degradation [272,277,278], most likely leading to the loss of cell polarity and facilitating tumour formation [279,280]”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [278]
Citations
Cites
The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“E7 was demonstrated to bind and inactivate the retinoblastoma tumour suppressor protein (pRB) (Dyson et al., 1989; MuÈ nger et al., 1989), as well as the related p107 and p130 proteins (Davies et al., 1993).”
BackgroundRecognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., & Cantley, L. C. (1997) · Science · doi:10.1126/science.275.5296.73 · Cited by 1,385
Research works printed but not linked: 35
- Anderson JM. . 1996 Curr. Biol. 6: 382–384. · DOI
- Banks L, Matlashewski G and Crawford L. . 1986 Eur. J. Biochem. 159: 529–534. · DOI
- Burnett AF, Barnes WA, Johnson JC, Grendys E, Willett GD, Barter JF and Doniger J. . 1992 Gynecol. Oncol. 47: 343–347. · DOI
- Chen J, Reid C, Band V and Androphy E. . 1995 Science 269: 529–531. · DOI · Paper page
- Cohen N, Benman J, Snyder S and Bredt D. . 1996 Neuron 17: 759–767. · DOI
- Crook T, Tidy JA and Vousden K. . 1991 Cell 67: 547–556. · DOI
- Davies R, Hicks R, Crook T, Morris J and Vousden K. . 1993 J. Virol. 67: 2521–2528. · DOI
- Doyle D, Lee A, Lewis J, Kim E, Sheng M and MacKinnon R. . 1996 Cell 85: 1067–1076. · DOI
- Goode S and Perrimon N. . 1997 Genes Dev. 11: 2532–2544. · DOI
- Gross-Mesilaty S, Reinstein E, Bercovich B, Tobias K, Schwartz A, Kahana C and Ciechanover A. . 1998 Proc. Natl. Acad. Sci. USA 95: 8058–8063. · DOI · Paper page
- Kim S. . 1997 Curr. Opin. Cell Biol. 9: 853–859. · DOI
- Kim E, Niethammer M, Rothschild A, Nung Jan Y and Sheng M. . 1995 Nature 378: 85–88. · DOI
- Kim E and Sheng M. . 1996 Neuropharm. 35: 993–1000. · DOI
- Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T and Ishibashi M. . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616. · DOI · Paper page
- Kühne C and Banks L. . 1998 J. Biol. Chem. 273: 34302–34309. · DOI
- Lee SS, Weiss R and Javier R. . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675. · DOI · Paper page
- Lue R, Marfatia S, Branton D and Chishti A. . 1994 Proc. Natl. Acad. Sci. USA 91: 9818–9822. · DOI
- Marfatia S, Morais Cabral J, Lin L, Hough C, Bryant P, Stolz L and Chishti A. . 1996 J. Cell Biol. 135: 753–766. · DOI
- Matlashewski G, Schneider J, Banks L, Jones N, Murray A and Crawford L. . 1987 EMBO J. 6: 1741–1746. · DOI · Paper page
- Muller B, Kistner U, Veh R, Cases-Langhoff C, Becker B, Gundelfinger E and Garner C. . 1995 J. Neurosci. 15: 2354–2366. · DOI
- Münger K, Werness B, Dyson N, Phelps W, Harlow E and Howley P. . 1989 EMBO J. 8: 4099–4105. · DOI · Paper page
- Ponting C and Phillips C. . 1995 Trends Biochem. Sci. 20: 102–103. · DOI
- Saras J and Heldin C. . 1996 Trends Biochem. Sci. 21: 455–458. · DOI
- Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM. . 1990 Cell 63: 1129–1136. · DOI · Paper page
- Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh I, Matlashewski G and Banks L. . 1998 Nature 393: 229–234. · DOI
- Thomas M and Banks L. . 1998 Oncogene 17: 2943–2954. · DOI · Paper page
- Tong X and Howley P. . 1997 Proc. Natl. Acad. Sci. USA 94: 4412–4417. · DOI
- Treier M, Staszewski LM and Bohmann D. . 1994 Cell 78: 787–798. · DOI
- Vousden K. . 1994 Adv. Cancer Res. 64: 1–24. · DOI
- Woods D and Bryant P. . 1991 Cell 66: 451–464. · DOI
- Woods D and Bryant P. . 1993 Mech. Dev. 44: 85–89. · DOI
- Woods D, Hough C, Peel D, Callaini G and Bryant P. . 1996 J. Cell Biol. 134: 1469–1482. · DOI · Paper page
- Zhang J, Rose BR, Thompson CH, Jarrett C, Russell P, Houghton RS and Cossart YE. . 1995 Gynecol. Oncol. 57: 170–177. · DOI
- zur Hausen H and Schneider A. . 1987 In: Salzman N and Howley PM. (eds.). The Papovaviridae. vol. 2. Plenum Press: New York pp. 245–263.
- zur Hausen H. . 1991 Virology 184: 9–13. · DOI
Cited by
scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila
Brumby, A. M., & Richardson, H. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg548 · Cited by 628
Ubiquitination Regulates PSD-95 Degradation and AMPA Receptor Surface Expression
Colledge, M., Snyder, E. M., Crozier, R. A., Soderling, J. A., Jin, Y., Langeberg, L. K., Lu, H., Bear, M. F., & Scott, J. D. (2003) · Neuron · doi:10.1016/s0896-6273(03)00687-1 · Cited by 567
Zhan, L., Rosenberg, A., Bergami, K. C., Yu, M., Xuan, Z., Jaffe, A. B., Allred, C., & Muthuswamy, S. K. (2008) · Cell · doi:10.1016/j.cell.2008.09.045 · Cited by 436
Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses
Javier, R. T., & Rice, A. P. (2011) · Journal of Virology · doi:10.1128/jvi.05410-11 · Cited by 198
Self-citationPearson, H. B., Perez-Mancera, P. A., Dow, L. E., Ryan, A., Tennstedt, P., Bogani, D., Elsum, I., Greenfield, A., Tuveson, D. A., Simon, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58509 · Cited by 185
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Self-citationStephens, R., Lim, K., Portela, M., Kvansakul, M., Humbert, P. O., & Richardson, H. E. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.01.011 · Cited by 132
Tan, M. J. A., White, E. A., Sowa, M. E., Harper, J. W., Aster, J. C., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205991109 · Cited by 132
The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction
Nagasaka, K., Pim, D., Massimi, P., Thomas, M., Tomaić, V, Subbaiah, V. K., Kranjec, C., Nakagawa, S., Yano, T., Taketani, Y., et al. (2010) · Oncogene · doi:10.1038/onc.2010.265 · Cited by 75
Self-citation
Metadata
- Authors
- Gardiol, D., Kühne, C., Glaunsinger, B., Lee, S. S., Javier, R., & Banks, L.
- Venue
- Oncogene
- Published
- 1999-09-30
- Volume
- 18
- Issue
- 40
- Pages
- 5487-5496
- ISSN
- 0950-9232
- 1476-5594
- Cited by
- 277
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review